India’s drug regulator has approved two coronavirus vaccines for emergency use, paving the way for a massive nation-wide inoculation program.
One vaccine was developed by UK-based AstraZeneca and Oxford University, the other by local company Bhar-at Biotech. The decision comes a day after India conducted a trial run of its vaccination drive, testing cold-chain infrastructure, delivery systems and storage platforms. The government hopes to vaccinate some 300 million people by July.
For more news go to: http://www.dw.com/en/
Follow DW on social media:
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/channel/deutschewelle
#Coronavirus #Vaccine #India